Selected article for: "therapeutic target and tumor development"

Author: Zhou, Yunxiang; Yao, Yihan; Deng, Yongchuan; Shao, Anwen
Title: Regulation of efferocytosis as a novel cancer therapy
  • Cord-id: z34j1434
  • Document date: 2020_5_5
  • ID: z34j1434
    Snippet: Efferocytosis is a physiologic phagocytic clearance of apoptotic cells, which modulates inflammatory responses and the immune environment and subsequently facilitates immune escape of cancer cells, thus promoting tumor development and progression. Efferocytosis is an equilibrium formed by perfect coordination among “find-me”, “eat-me” and “don’t-eat-me” signals. These signaling pathways not only affect the proliferation, invasion, metastasis, and angiogenesis of tumor cells but als
    Document: Efferocytosis is a physiologic phagocytic clearance of apoptotic cells, which modulates inflammatory responses and the immune environment and subsequently facilitates immune escape of cancer cells, thus promoting tumor development and progression. Efferocytosis is an equilibrium formed by perfect coordination among “find-me”, “eat-me” and “don’t-eat-me” signals. These signaling pathways not only affect the proliferation, invasion, metastasis, and angiogenesis of tumor cells but also regulate adaptive responses and drug resistance to antitumor therapies. Therefore, efferocytosis-related molecules and pathways are potential targets for antitumor therapy. Besides, supplementing conventional chemotherapy, radiotherapy and other immunotherapies with efferocytosis-targeted therapy could enhance the therapeutic efficacy, reduce off-target toxicity, and promote patient outcome.

    Search related documents:
    Co phrase search for related documents
    • activation recruitment and adaptive immune response: 1, 2, 3, 4
    • activation recruitment and adaptive immunity: 1, 2, 3, 4, 5
    • activation recruitment and adaptive response: 1, 2, 3, 4, 5
    • activation recruitment and adp ribose: 1
    • activation recruitment and adp ribose polymerase: 1
    • activation recruitment and macrophage induce: 1
    • activator transducer and adaptive immune cell: 1
    • activator transducer and adaptive immune response: 1, 2, 3, 4
    • activator transducer and adaptive immunity: 1, 2
    • activator transducer and adaptive response: 1, 2, 3, 4, 5
    • activator transducer and lung cancer: 1, 2, 3
    • activator transducer and m1 macrophage: 1
    • activator transducer and macrophage polarization: 1, 2, 3
    • adaptive immune cell and macrophage polarization: 1, 2
    • adaptive immune response and lung cancer: 1
    • adaptive immune response and lymphocyte proliferation: 1, 2
    • adaptive immune response and lymphocyte release: 1, 2
    • adaptive immune response and mabs monoclonal antibody: 1
    • adaptive immune response and macrophage polarization: 1, 2